Neurocrine Biosciences Inc (NAS:NBIX)
$ 126.59 -1.32 (-1.03%) Market Cap: 12.82 Bil Enterprise Value: 11.84 Bil PE Ratio: 33.94 PB Ratio: 4.71 GF Score: 85/100

Neurocrine Biosciences Inc at Evercore HealthCONx Conference Transcript

Dec 03, 2019 / 01:45PM GMT
Release Date Price: $117.64 (+0.75%)
Ravindra Mehrotra
Evercore ISI Institutional Equities, Research Division - Senior MD

Good morning. My name is Ravi Mehrotra. I'm a senior biotechnologist at Evercore ISI. It gives me great pleasure to have Neurocrine with us today. We have Kevin, Matt and Kyle. We've got an awful lot to go through today, and thank you so much for getting a deal done just before presenting. So we'll definitely talk about that.

Questions & Answers

Ravindra Mehrotra
Evercore ISI Institutional Equities, Research Division - Senior MD

But Kevin, an easy one for you. Just -- I think we all know the company, but give us just about 3-minute overview of Neurocrine.

Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director

Yes, I'll do a real quick one here. Basically, the concept behind Neurocrine is that we're a neuroscience company. We've always been dedicated to neuroscience, particularly with the intersection of neuroendocrinology and neuropsychiatry. So not just straight neuroscience. We focus on devastating diseases

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot